Clinicopathologic significance of legumain overexpression in cancer: a systematic review and meta-analysis

@article{Zhen2015ClinicopathologicSO,
  title={Clinicopathologic significance of legumain overexpression in cancer: a systematic review and meta-analysis},
  author={Ye Zhen and Guo Chun-lei and Shen Wenzhi and Zhao Shuangtao and Luo Na and Wang Rong-rong and Luo Xiaohe and Niu Hai-ying and Luo De-hong and Jiang Shan and Tan Xiaoyue and Xiang Rong},
  journal={Scientific Reports},
  year={2015},
  volume={5}
}
  • Ye Zhen, Guo Chun-lei, +9 authors Xiang Rong
  • Published 2015
  • Medicine, Biology
  • Scientific Reports
  • Since reports on the clinical significance of legumain in cancer have shown inconsistent results, we systematically evaluated clinical indicators of legumain in cancer. We searched the Cochrane Library, PubMed, Embase, and EBSCO databases and the Wangfang and CNKI databases in China by using “legumain” and (“neoplasms” OR “cancer”) as search terms. We included case-controlled studies of legumain and cancer. The quality of the studies was evaluated by using Lichtenstein’s guidelines, and valid… CONTINUE READING

    Figures, Tables, and Topics from this paper.

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 24 CITATIONS, ESTIMATED 52% COVERAGE

    FILTER CITATIONS BY YEAR

    2016
    2020

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 52 REFERENCES

    Legumain protein as a potential predictive biomarker for Asian patients with breast carcinoma.

    VIEW 1 EXCERPT

    Legumain: a biomarker for diagnosis and prognosis of human ovarian cancer.

    VIEW 1 EXCERPT